Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for HLB Innovation Co., Ltd. (024850:KRX), powered by AI.
HLB Innovation Co., Ltd. is currently trading at ₩23,100. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for HLB Innovation Co., Ltd. on Alpha Lenz.
HLB Innovation Co., Ltd.'s P/E ratio is -160.9.
“HLB Innovation Co., Ltd. trades at a P/E of -160.9 (undervalued) with modest ROE of -8.1%.”
Ask for details →HLB Innovation Co., Ltd. is a company primarily engaged in pharmaceutical research and biotechnology development. This company focuses on innovative healthcare solutions, aiming to address global health challenges through advanced biotechnological applications. HLB Innovation is known for its strong commitment to R&D, concentrating on the development of novel drugs and therapeutic solutions. It operates in various sectors of the biotechnology industry, particularly in areas related to cancer treatment and regenerative medicine. With a robust portfolio of patents and proprietary technologies, the company positions itself as a key player in the biopharmaceutical landscape. HLB Innovation works with both domestic and international markets, collaborating with research institutions and other pharmaceutical companies to enhance its global impact. Its strategic involvement in cutting-edge scientific advancements contributes significantly to the evolving needs of the medical field. This company's activities are crucial in the pharmaceutical market as it drives innovation and supports the development of next-generation medical treatments.
“HLB Innovation Co., Ltd. trades at a P/E of -160.9 (undervalued) with modest ROE of -8.1%.”
Ask for details →HLB Innovation Co., Ltd. (ticker: 024850) is a company listed on KRX in the Technology sector (Semiconductor Equipment & Materials). Market cap is $733.0B.
The current price is ₩23,100 with a P/E ratio of -160.92x and P/B of 8.08x.
ROE is -8.13% and operating margin is -46.86%. Annual revenue is $25.4B.